Is Augmentin (amoxicillin-clavulanate) effective in treating urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin for Urinary Tract Infections

Amoxicillin-clavulanic acid (Augmentin) is recommended as a first-choice antibiotic for treating lower urinary tract infections according to the most recent WHO Essential Medicines guidelines. 1

Efficacy and Recommendations

The WHO Expert Committee specifically lists amoxicillin-clavulanic acid as a first-choice "Access" antibiotic for lower urinary tract infections, alongside sulfamethoxazole-trimethoprim 1. This recommendation is supported by data showing that the susceptibility of E. coli (the most common UTI pathogen) to amoxicillin-clavulanic acid in urinary isolates remains generally high in both adults and children.

However, it's important to note that:

  • The American Urological Association recommends avoiding beta-lactams (including Augmentin) as first-line therapy due to higher recurrence rates and potential collateral damage effects 2
  • First-line options recommended by American guidelines include:
    • Nitrofurantoin 100 mg twice daily for 5 days
    • Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 3 days (if local resistance <20%)
    • Fosfomycin 3 g single dose 2

Clinical Evidence

Early studies have demonstrated Augmentin's effectiveness in treating UTIs:

  • A 1984 study showed microbiological cure rates of 84% one week after treatment and 67% one month later in patients with recurrent UTIs 3
  • A 1992 study found that only 12% of patients treated with Augmentin failed to respond to treatment 4

However, a comparative study from 1983 showed that co-trimoxazole had a significantly higher cure rate (100%) compared to Augmentin (83%) for uncomplicated UTIs 5.

Treatment Approach

When considering Augmentin for UTI treatment:

  1. Obtain a urine culture before starting antibiotics to confirm the causative pathogen and determine susceptibility 2
  2. Consider local resistance patterns - Augmentin maintains good activity against many E. coli strains, including some that are resistant to amoxicillin alone 6
  3. Standard dosing is typically 375 mg three times daily 6
  4. Treatment duration:
    • 3-5 days for uncomplicated UTI
    • 7-14 days for complicated UTI 2

Caveats and Considerations

  • Side effects: About 20% of patients may experience side effects with Augmentin, primarily gastrointestinal (diarrhea, abdominal pain) 5, 3
  • Resistance concerns: Some studies have reported treatment failures due to Augmentin-resistant organisms 5
  • For upper UTIs (pyelonephritis): Augmentin is not listed as a first-choice option; instead, ciprofloxacin is recommended for mild-to-moderate cases and ceftriaxone/cefotaxime for severe cases 1
  • For complicated UTIs or systemic symptoms: Consider parenteral therapy with broader-spectrum antibiotics 2

Best Practice Approach

  1. For uncomplicated lower UTIs, Augmentin is an appropriate option, especially in regions where it's recommended by local guidelines
  2. Obtain a urine culture before starting treatment
  3. Consider local resistance patterns when selecting empiric therapy
  4. Adjust therapy based on culture results
  5. Use the shortest effective duration of antibiotics
  6. Monitor for gastrointestinal side effects

In conclusion, while Augmentin is effective for treating UTIs and is recommended by WHO guidelines, other options like nitrofurantoin, TMP-SMX, and fosfomycin may be preferred in some regions based on local resistance patterns and guideline recommendations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.